Rajabi-Naeeni, Masoumeh
Dolatian, Mahrokh
Qorbani, Mostafa
Vaezi, Amir Abbas
Funding for this research was provided by:
Shahid Beheshti University of Medical Sciences
Article History
Received: 29 July 2019
Accepted: 2 December 2019
First Online: 30 December 2019
Ethics approval and consent to participate
: The Ethics Committee of Shahid Beheshti University of Medical Sciences has approved the study protocol (IR.SBMU.RETECH.REC.1397.615). A written informed consent form will be signed and dated by participants and investigators at the beginning of the study (in Persian).Participation is free and a patient can withdraw at whatever point the person feels they are unable to continue. The personal information of participants will be kept secret before, during, and after the trial. Side effects of the supplements have not been reported in previous studies but anyone who has a complaint about the complications of the intervention can refer to the center of the Ethics Committee and get compensation.
: Not applicable.
: The authors declare that they have no competing interests.